Notice of AGM | 31-Oct-2023 | 12:00 | RNS |
Results for the Year Ended 30 April 2023 | 31-Oct-2023 | 07:00 | RNS |
Update on Final Results | 20-Oct-2023 | 07:00 | RNS |
Scancell to speak at World Vaccine Congress Europe | 18-Oct-2023 | 07:00 | RNS |
Block Listing Six Monthly Return | 17-Oct-2023 | 07:00 | RNS |
Change of Date for Final Results | 11-Oct-2023 | 07:00 | RNS |
Notice of Final Results and Investor Presentation | 03-Oct-2023 | 07:00 | RNS |
Positive data from Phase 2 SCOPE trial with SCIB1 | 19-Sep-2023 | 07:00 | RNS |
Scancell to present three posters at ICI | 14-Sep-2023 | 07:00 | RNS |
Scancell Appoints Head of Business Development | 07-Sep-2023 | 07:00 | RNS |
Scancell Appoints Sath Nirmalananthan as CFO | 29-Aug-2023 | 07:00 | RNS |
Modi-1 trial open for expansion in CPI combination | 31-Jul-2023 | 07:00 | RNS |
Extension of exercise period for CEO share options | 13-Jul-2023 | 09:14 | RNS |
Pipeline strategy and business update | 10-Jul-2023 | 07:00 | RNS |
Scancell to Present Modi-1 Data at ASCO | 02-Jun-2023 | 07:00 | RNS |
Currency | UK Pounds |
Share Price | 10.10p |
Change Today | -0.15p |
% Change | -1.46 % |
52 Week High | 17.00 |
52 Week Low | 8.15 |
Volume | 245,570 |
Shares Issued | 927.98m |
Market Cap | £93.73m |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth | ![]() |
---|
Strong Buy | 0 |
Buy | 2 |
Neutral | 0 |
Sell | 0 |
Strong Sell | 0 |
Total | 2 |
No dividends found |
Time | Volume / Share Price |
16:24 | 49,000 @ 10.06p |
15:43 | 956 @ 10.45p |
15:05 | 47,801 @ 10.46p |
14:31 | 48 @ 10.06p |
14:24 | 10,087 @ 9.80p |
CEO | Lindy Durrant |
CFO | Sath Nirmalananthan |
You are here: research